RSS-Feed abonnieren
DOI: 10.1055/s-0028-1109812
© Georg Thieme Verlag KG Stuttgart · New York
Contrast-Enhanced Ultrasound Pattern of Splenic Metastases – a Retrospective Study in 32 Patients
Kontrastunterstützte sonografische Befunde bei Milzmetastasen – eine restrospektive Studie an 32 PatientenPublikationsverlauf
received: 16.5.2009
accepted: 3.9.2009
Publikationsdatum:
06. November 2009 (online)

Zusammenfassung
Ziel: Ziel ist die Charakterisierung von Milzmetastasen in der kontrastmittelunterstützten Sonografie (CEUS) und die Evaluation der diagnostischen Wertigkeit im Vergleich zur konventionellen B-Bild-Sonografie. Material und Methoden: Von Januar 2004 März 2009 wurde bei ca. 50 000 abdominellen B-Bild-Sonografien n = 279 Fällen (< 0,6 %) eine fokale Milzläsion detektiert. Bei n = 32 (11,5 %) bestand der hochgradige Verdacht auf Milzmetastasierung von unterschiedlichen soliden Tumoren. Die Läsionen wurden im B-Bild hinsichtlich Anzahl, Größe, Echogenität, Häufigkeiten von Halozeichen und Nekrosebildung untersucht. In der CEUS wurde das Ausmaß der Kontrastmittelanreicherung im Vergleich zum umgebenden Milzgewebe während der arteriellen (5 – 30 s) und parenchymatösen Phase (3 – 5 min) bestimmt. Alle Daten wurden retrospektiv ausgewertet. Ergebnisse: Im B-Bild waren die Läsionen solitär n = 18 (56 %), multiple n = 14 (44 %), < 2 cm n = 11 (34 %), ≥ 2 cm n = 21 (66 %), echoarm n = 14 (44 %), isoechogen n = 12 (38 %), echoreich n = 6 (19 %), glatt begrenzt n = 27 (84 %) irregulär begrenzt n = 5 (16 %). In der arteriellen Phase der CEUS waren die Läsionen hypoechogen n = 21 (66 %), isoechogen n = 3 (6 %), hyperechogen n = 1(3 %) und komplex n = 8 (25 %). In der parenchymatösen Phase waren die Läsionen hypoechogen n = 24 (75 %) und komplex n = 8 (25 %). In n = 12 (38 %) Fällen konnte mittels CEUS eine bessere Darstellung der Milzmetastasen erzielt werden. Schlussfolgerung: Milzmetastasen zeigen sowohl in der arteriellen als auch parenchymalen Phase der CEUS eine verminderte Kontrastmittelanreicherung. CEUS kann bei ca. 40 % der Patienten die Darstellung der Milzmetastasen im Vergleich zur B-Bild-Sonografie verbessern.
Abstract
Purpose: To characterize the pattern of contrast-enhanced ultrasonography (CEUS) in splenic metastases compared to standard B-mode ultrasonography. Materials and Methods: Between January 2004 and March 2009, about 50,000 abdominal ultrasound examinations were performed, and n = 279 (< 0.6 %) of focal splenic lesions were detected of which n = 32 (11.5 %) were highly suggestive for splenic metastases of various solid tumors. The number of lesions, size, echogenicity, rim appearance, presence of halo sign and necrosis were recorded via B-mode sonography. Contrast enhancement was determined in the arterial phase (5 – 30 sec) and parenchymal phase (3 – 5 min). B-mode sonography and CEUS were compared in terms of the visibility of splenic metastases. All data was evaluated retrospectively. Results: On B-mode sonography lesions were solitary n = 18 (56 %), multiple n = 14 (44 %), < 2 cm n = 11 (34 %), ≥ 2 cm n = 21 (66 %), hypoechoic n = 14 (44 %), isoechoic n = 12 (38 %) and hyperechoic n = 6 (19 %), with regular rim appearance n = 27 (84 %), and with irregular rim appearance n = 5 (16 %). During the arterial phase CEUS lesions were hypoechoic n = 21 (66 %), isoechoic n = 2 (6 %), hyperechoic n = 1 (3 %) and complex n = 8 (25 %). During the parenchymal phase lesions were hypoechoic n = 24 (75 %) and complex n = 8 (25 %). CEUS provided improved visualization of splenic metastases in n = 12 (38 %) cases. Conclusion: CEUS of splenic metastases is characterized by reduced contrast enhancement in both the arterial and the parenchymal phase in most cases. Moreover, CEUS improved the visualization of splenic metastases in about 40 % of cases in comparison to standard B-mode sonography.
Key words
spleen - contrast-enhanced ultrasonography - splenic metastases - focal splenic lesions
References
- 1
Lam K Y, Tang V.
Metastatic Tumors to the spleen: A 25-Year Clinopathologic Study.
Arch Pathol Lab Med.
2000;
124
526-530
Reference Ris Wihthout Link
- 2
Marymont J H, Gross S.
Patterns of metastatic cancer in the spleen.
Am J Clin Pathol.
1963;
40
58-66
Reference Ris Wihthout Link
- 3
Börner N, Blank W, Bönhof J. et al .
Echogenic splenic lesions-incidence and differential diagnosis.
Ultraschall in Med.
1990;
11
112-118
Reference Ris Wihthout Link
- 4
Görg C, Schwerk W B, Görg K.
Splenic lesions: sonographic patterns, follow-up, differential diagnosis.
Eur J Radiol.
1991;
13
59-66
Reference Ris Wihthout Link
- 5 Görg C, Schwerk W B. Milz. Ultraschalldiagnostik: Lehrbuch und Atlas ECO-MED 2000 21: 1-137
Reference Ris Wihthout Link
- 6
Popović M, Barisić G, Krivokapić Z.
Isolated splenic metastases of colorectal carcinoma – case report and review of literature.
Acta Chir Iugosl.
2008;
55
73-76
Reference Ris Wihthout Link
- 7
Schmidt B J, Smith S L.
Isolated splenic metastasis from primary lung adenocarcinoma.
South Med J.
2004;
97
298-300
Reference Ris Wihthout Link
- 8
Giuliani A, Caporale A, Di Bari M. et al .
Isolated splenic metastasis from endometrial carcinoma.
J Exp Clin Cancer Res.
1999;
18
93-96
Reference Ris Wihthout Link
- 9
Capizzi P J, Allen K B, Amerson J R. et al .
Isolated splenic metastasis from rectal carcinoma.
South Med J.
1992;
85
1003-1005
Reference Ris Wihthout Link
- 10
Siniluoto T, Päivänsalo M, Tikkakoski T. et al .
Ultrasound-guided aspiration cytology of the spleen.
Acta Radiol.
1992;
33
137-139
Reference Ris Wihthout Link
- 11
Civardi G, Vallisa D, Bertè R. et al .
Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low
risk in a multicenter Italian study.
Am J Hematol.
2001;
67
93-99
Reference Ris Wihthout Link
- 12
Venkataramu N K, Gupta S, Sood B P. et al .
Ultrasound guided fine needle aspiration biopsy of splenic lesions.
Br J Radiol.
1999;
72
953-956
Reference Ris Wihthout Link
- 13
Lal A, Ariga R, Gattuso P. et al .
Splenic fine needle aspiration and core biopsy. A review of 49 cases.
Acta Cytol.
2003;
47
951-959
Reference Ris Wihthout Link
- 14
Wernecke K, Peter P E, Krüger K G.
Ultrasonographic patterns of focal hepatic and splenic lesions in Hodgkin`s and non
Hodgkin’s lymphoma.
BJR.
1987;
60
655-660
Reference Ris Wihthout Link
- 15
Bert T, Görg C.
Was sollte man mit sonographisch zufällig entdeckten Milztumoren machen?.
Ultraschall.
2006;
27
P 6.5
Reference Ris Wihthout Link
- 16
Quaia E, Calliada F, Bertolotto M. et al .
Characterization of focal liver lesions with contrast-specific US modes and a sulfur
hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Radiology.
2004;
232
420-423
Reference Ris Wihthout Link
- 17
Dietrich F C.
Comments and illustrations regarding the guidelines and good clinical practice recommendations
of contrast-enhanced ultrasound (CEUS)-update 2008.
Ultraschall in Med.
2008;
29
188-202
Reference Ris Wihthout Link
- 18
Oldenburg A, Albrecht T.
Baseline and contrast-enhanced ultrasound of the liver in tumor patients.
Ultraschall in Med.
2008;
29
488-498
Reference Ris Wihthout Link
- 19
Dai Y, Chen M H, Yin S S. et al .
Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant
from benign lesions?.
Invest Radiol.
2007;
42
596-603
Reference Ris Wihthout Link
- 20
Dietrich C F, Schreiber-Dietrich D, Schuessler G. et al .
Contrast enhanced ultrasound of the liver – state of the art.
Dtsch Med Wochenschr.
2007;
132
1225-1231
Reference Ris Wihthout Link
- 21
Konopke R, Kersting S, Saeger H D. et al .
Detection of liver lesions by contrast-enhanced ultrasound – comparison to intraoperative
findings.
Ultraschall in Med.
2005;
26
107-113
Reference Ris Wihthout Link
- 22
Braun B.
Focal liver processes: ”better is the enemy of good”: CEUS in the fast lane.
Ultraschall in Med.
2009;
30
329-332
Reference Ris Wihthout Link
- 23
Strobel D, Seitz K, Blank W. et al .
Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma,
hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver
lesions in contrast-enhanced ultrasound (CEUS).
Ultraschall in Med.
2009;
30
376-382
Reference Ris Wihthout Link
- 24
Seitz K, Strobel D, Bernatik T. et al .
Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions
– prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial).
Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008,
Davos.
Ultraschall in Med.
2009;
30
383-389
Reference Ris Wihthout Link
- 25
Dörffel Y, Wermke W.
Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Ultraschall in Med.
2008;
29
506-514
Reference Ris Wihthout Link
- 26
Hofer S, Oberholzer C, Beck S. et al .
Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver
metastases.
Ultraschall in Med.
2008;
29
388-392
Reference Ris Wihthout Link
- 27
Strobel D, Seitz K, Blank W. et al .
Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic
accuracy in clinical practice (DEGUM multicenter trial).
Ultraschall in Med.
2008;
29
499-505
Reference Ris Wihthout Link
- 28
Seitz K.
CEUS for liver tumors: facts, studies, relevance, and reality in the clinical routine.
Ultraschall in Med.
2008;
29
485-487
Reference Ris Wihthout Link
- 29
Seitz K, Judmaier G.
The extended repertoire of sonography: contrast enhancement, radio frequency ablation
and puncture.
Ultraschall in Med.
2007;
28
158-160
Reference Ris Wihthout Link
- 30
Dietrich C, Hartung E, Ignee A.
The use of contrast-enhanced ultrasound in patients with GIST metastases that are
negative in CT and PET.
Ultraschall in Med.
2008;
29
276-277
Reference Ris Wihthout Link
- 31
Bauditz J, Schade T, Wermke W.
Sonographic diagnosis of hilar cholangiocarcinomas by the use of contrast agents.
Ultraschall in Med.
2007;
28
161-167
Reference Ris Wihthout Link
- 32
Mitterberger M, Pelzer A, Colleselli D. et al .
Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions.
Eur J Radiol.
2007;
64
231-238
Reference Ris Wihthout Link
- 33
Setola S V, Catalano O, Sandomenico F. et al .
Contrast-enhanced sonography of the kidney.
Abdom Imaging.
2007;
32
21-28
Reference Ris Wihthout Link
- 34
Catalano O, Lobiano R, Sandomenico F.
Splenic trauma: evaluation with contrast-specific sonography and a second-generation
contrast medium.
J Ultrasound in Med.
2003;
22
467-477
Reference Ris Wihthout Link
- 35
Görg C.
The forgotten organ: contrast enhanced sonography of the spleen.
European J Radiol.
2007;
64
189-201
Reference Ris Wihthout Link
- 36
Görg C, Graef C, Bert T.
Contrast-enhanced sonography for differential diagnosis of an inhomogeneous spleen
of unknown cause in patients with pain in the left upper quadrant.
J Ultrasound Med.
2006;
25
729-734
Reference Ris Wihthout Link
- 37
Görg C, Bert T.
Contrast-enhanced sonography of focal splenic lesions with a second-generation contrast
agent.
Ultraschall in Med.
2005;
26
470-477
Reference Ris Wihthout Link
- 38
Görg C, Bert T.
Second-generation sonographic contrast agent for differential diagnosis of perisplenic
lesions.
Am J Roentgenol.
2006;
186
621-626
Reference Ris Wihthout Link
- 39
Lim A K, Patel N, Eckersley R J. et al .
Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative
study in healthy volunteers.
Radiology.
2004;
231
785-788
Reference Ris Wihthout Link
- 40
Claudon M, Cosgrove D, Albrecht T. et al .
Guidelines an good clinical practise recommendations for contrast enhanced ultrasound
(CEUS)-update 2008.
Ultraschall in Med.
2008;
29
28-44
Reference Ris Wihthout Link
- 41
Görg C, Hoffmann A.
Metastases to the spleen in 59 cancer patients: A 14-year clinicosonographic study.
Ultraschall in Med.
2008;
29
173-178
Reference Ris Wihthout Link
- 42
Görg C, Görg K, Bert T. et al .
Colour Doppler sonographic patterns and clinical follow-up of incidentally found increased
vascular hypoechoic tumors: evidence for a benign tumor.
British J Radiol.
2006;
79
319-325
Reference Ris Wihthout Link
Dr. Albrecht Neesse
Gastroenterology, Endocrinology and Metabolism, University of Marburg
Baldingerstr.
35043 Marburg
Germany
Telefon: ++ 49/64 21/5 86 64 60
Fax: ++ 49/64 21/5 86 89 22
eMail: neesse@med.uni-marburg.de

